1. Home
  2. BOLT vs SONM Comparison

BOLT vs SONM Comparison

Compare BOLT & SONM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • SONM
  • Stock Information
  • Founded
  • BOLT 2015
  • SONM 1999
  • Country
  • BOLT United States
  • SONM United States
  • Employees
  • BOLT N/A
  • SONM N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • SONM Telecommunications Equipment
  • Sector
  • BOLT Health Care
  • SONM Telecommunications
  • Exchange
  • BOLT Nasdaq
  • SONM Nasdaq
  • Market Cap
  • BOLT 10.4M
  • SONM 12.1M
  • IPO Year
  • BOLT 2021
  • SONM 2019
  • Fundamental
  • Price
  • BOLT $6.17
  • SONM $0.68
  • Analyst Decision
  • BOLT Buy
  • SONM
  • Analyst Count
  • BOLT 3
  • SONM 0
  • Target Price
  • BOLT $47.50
  • SONM N/A
  • AVG Volume (30 Days)
  • BOLT 33.8K
  • SONM 1.6M
  • Earning Date
  • BOLT 11-11-2025
  • SONM 11-12-2025
  • Dividend Yield
  • BOLT N/A
  • SONM N/A
  • EPS Growth
  • BOLT N/A
  • SONM N/A
  • EPS
  • BOLT N/A
  • SONM N/A
  • Revenue
  • BOLT $4,167,000.00
  • SONM $57,917,000.00
  • Revenue This Year
  • BOLT N/A
  • SONM $127.68
  • Revenue Next Year
  • BOLT N/A
  • SONM N/A
  • P/E Ratio
  • BOLT N/A
  • SONM N/A
  • Revenue Growth
  • BOLT N/A
  • SONM N/A
  • 52 Week Low
  • BOLT $4.59
  • SONM $0.52
  • 52 Week High
  • BOLT $14.36
  • SONM $6.38
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 63.23
  • SONM 53.90
  • Support Level
  • BOLT $5.13
  • SONM $0.59
  • Resistance Level
  • BOLT $6.20
  • SONM $0.67
  • Average True Range (ATR)
  • BOLT 0.32
  • SONM 0.07
  • MACD
  • BOLT 0.07
  • SONM 0.00
  • Stochastic Oscillator
  • BOLT 87.19
  • SONM 34.28

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About SONM Sonim Technologies Inc.

Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company sells mobile phones, accessories, and solutions to AT&T, T-Mobile, and Verizon in the Canada, and to Bell, Rogers, and Telus and Rogers, Telstra in Australia. The products include rugged mobile phones that can attach to both public and private wireless networks, industrial-grade accessories that meet the requirements of specific applications and software applications, and cloud-based tools that provide management and deployment services to customers. The company generates revenue from discounts, price protection, and customer incentives.

Share on Social Networks: